CN1429594A - Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method - Google Patents

Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method Download PDF

Info

Publication number
CN1429594A
CN1429594A CN 01145563 CN01145563A CN1429594A CN 1429594 A CN1429594 A CN 1429594A CN 01145563 CN01145563 CN 01145563 CN 01145563 A CN01145563 A CN 01145563A CN 1429594 A CN1429594 A CN 1429594A
Authority
CN
China
Prior art keywords
separator
supercritical
extraction
raw material
poria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 01145563
Other languages
Chinese (zh)
Inventor
王予刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI ZHANWAN BIOLOGICAL PRODUCT CO Ltd
Original Assignee
SHANGHAI ZHANWAN BIOLOGICAL PRODUCT CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI ZHANWAN BIOLOGICAL PRODUCT CO Ltd filed Critical SHANGHAI ZHANWAN BIOLOGICAL PRODUCT CO Ltd
Priority to CN 01145563 priority Critical patent/CN1429594A/en
Publication of CN1429594A publication Critical patent/CN1429594A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A process for extracting the active components from raw plant materials by the supercritical Co2 extraction method in order to regulate blood sugar and treat II-type diabetes is disclosed, and it features that the said raw plant materials are mulberry leaf 33-34 wt.%, tuckahoe 33-34 wt.% and yam 34-35 wt.%.

Description

Use supercritical CO 2Extraction extracts raw material of blood sugar regulation in the plant and preparation method thereof
Technical field:
The invention belongs to field of medicaments and nutritional health food field, specifically raw material of a kind of blood sugar regulation and preparation method thereof.
Background technology:
China diabetes association adds up domestic diabetics to have reached 40,000,000 in November, 2000, and patient is also constantly increasing every year, though antidiabetic drug is large in the variety in the market, but the Rezulin product that domestic and international diabetic is taken only play blood sugar lowering basically and keep the effect of symptom, cure far from, and the product that reaches ideal treatment does not almost have.
Technology contents:
The object of the present invention is to provide a kind of supercritical CO of using 2Extraction extracts raw material of blood sugar regulation in the plant and preparation method thereof.
Technical scheme of the present invention is achieved in that uses supercritical CO 2Extraction extracts the raw material of blood sugar regulation in the plant, and it is characterized in that: described raw material is Powdered and is made up of Folium Mori, Poria, Rhizoma Dioscoreae, and their weight percentages of components is Folium Mori 33~34%, Poria 33~34%, Rhizoma Dioscoreae 34~35%.
Use supercritical CO 2Extraction extracts the preparation method of the raw material of blood sugar regulation in the plant, it is characterized in that:
A. Folium Mori, Poria, Rhizoma Dioscoreae 3 flavor Chinese medicines are cleaned up section, section back natural drying, crushed after being dried becomes 65~70 order powder;
B. adopt supercritical CO 2Fluid extraction technology extracts, and is specially: Folium Mori, Poria, 3 kinds of Chinese medicinal powder of Rhizoma Dioscoreae are placed extractor, begin to supply with supercritical CO 2Extraction, condition is pressure 38~46MPa, 38~45 ℃ of temperature, supercritical CO 2The extractor of from bottom to top flowing through, extracting solution flows to first separator after the air relief valve decompression, contain the glycoside product and be insoluble to CO under the pressure about 7MPa 2Be deposited in the separator bottom, extracting solution flows into second separator by first separator after reducing pressure, contain polysaccharide material and be insoluble to CO under the pressure about 2MPa 2, this moment, temperature was controlled at 18~21 ℃, the required bottom that polysaccharide material is deposited in separator, the CO of containing 2Reclaim through second separator, the semi-finished product after secondary separates are the extractum shape, all take out;
C. the fast household freezer that extractum shape semi-finished product are taken out through-183 ℃ is frozen into lyophilized powder;
D. pulverize dry powder at least 100 purpose powder and sieve.
The present invention is owing to be smart powder to the extraction of wild plant extract, effect with treatment diabetes, main treatment target is the type ii diabetes patient, reach and control the effect that table effects a permanent cure, show through experimental result, this prescription significantly blood sugar lowering, urine is sick, the balance endocrine, improves the function of islets of langerhans, makes it recover normal.Though antidiabetic drug is large in the variety on the market now, but the product that reaches therapeutic effect does not almost have, now the eutherapeutic product of therapeutical effect is badly in need of having in the domestic and international market, carries the powder compatibility to together because our new product Main Ingredients and Appearance is wild plant Folium Mori, Poria, Rhizoma Dioscoreae essence.Played the balance endocrine, reached and control the table effect of effecting a permanent cure, with to put into practice curative effect good, these product all had the curative effect of uniqueness to type ii diabetes through the scientific researches in 3 years.The method of medicinal supercritical extraction is extracted in its prescription, improved drug quality, few consumption just plays better curative effect, than also 3~5 days in advance common Chinese antihypelipidemic preparation onset time, this product compares with domestic and international similar drug, effect is remarkable, and following table 1 is for taking the inhibiting statistical table of different pharmaceutical to hyperglycemia.
Table 1
Medicine Example number n Different time blood sugar increasing percentage rate X ± SE The place of production
1 hour 2 hours
Diamicron 0.5g ????120 ????132.9±19.7 ??141.0±22.4 Germany
This product 0.5g ????120 ????52.5±11.7 ??68.8±18.8 Our company
This product 1.0g ????120 ????31.6±12.9 ??26.8±19.9 Our company
Table 2 sample is to the influence of the anti-blood glucose value of zoic model with hyperglycemia (X ± SD)
Group Number of animals (only) Blood glucose difference (mmol/L)
0.5-0 (hour) 2-0.5 (hour)
Hyperglycemia model ????10 ????8.2±2.8 ????-8.7±3.3
Low dosage ????10 ????8.2±2.9 ????-10.7±5.7
Middle dosage ????10 ????9.0±3.3 ????-12.3±4.9
High dose ????10 ????8.5±3.8 ????-17.6±4.8 *
*(through variance analysis) compared with the hyperglycemia model group in P<0.05
This product has the effect of remarkable inhibition hyperglycemia as can be seen from Table 1, and experimental group is taken 1.0g, can significantly suppress blood sugar increasing, takes for a long time to have no side effect, and cure rate reaches 30~35%, and table 1 explanation this product has more superiority than commercially available antihypelipidemic product.
By table 2 as seen, the blood glucose difference of sample high dose phase in the time of 2-0.5 hour is compared with the hyperglycemia model group, and significant difference is arranged.
Description of drawings:
Fig. 1 is the preparation method sketch map of one embodiment of the invention
The specific embodiment:
Below the invention will be further described, and provide embodiment.
The present invention is for using supercritical CO 2Extraction extracts the raw material of blood sugar regulation in the plant, it is different from prior art and is: raw material is that powder is made up of Folium Mori, Poria, Rhizoma Dioscoreae, their weight percentages of components is, Folium Mori 33~34%, Poria 33~34%, Rhizoma Dioscoreae 34~35%, component in this raw material powder contains Folium Mori, globulariacitrin, polypeptide, Poria-pachyman, polysaccharide, Rhizoma Dioscoreae, dioscin, can make the islets of langerhans restore funcitons, reach the purpose of radical cure.Folium Mori function dispelling wind and heat pathogens in the raw material powder, liver heat removing and eyesight improving, the effect of polypeptide can stimulate insulin secretion, and slows down the degraded deactivation of insulin in peripheral tissues, thus rising insulinemia concentration and blood sugar lowering; The Poria function: spleen invigorating and in, mind tranquilizing and the heart calming, promoting diuresis to eliminate damp pathogen, quench the thirst; The pachyman pachymic acid has blood sugar reducing function, Rhizoma Dioscoreae function tonifying the spleen and stomach, lung benefiting kidney; Polysaccharide C, D all have the function of hypoglycemic activity.
Use supercritical CO 2Extraction extracts the preparation method of the raw material of blood sugar regulation in the plant, it is characterized in that:
A. press the percentage by weight of Folium Mori 33~34%, Poria 33~34%, Rhizoma Dioscoreae 34~35%, Folium Mori and other 2 flavor Chinese medicine are cleaned up section, section back natural drying, crushed after being dried becomes 65~70 order powder;
B. adopt supercritical CO 2Fluid extraction technology extracts, and is specially: the powder of Folium Mori, Poria, Rhizoma Dioscoreae is placed extractor, begin to supply with supercritical CO 2Extraction, condition is pressure 38~46MPa, 38~45 ℃ of temperature, supercritical CO 2The extractor of from bottom to top flowing through, extracting solution flows to first separator after the air relief valve decompression, contain the glycoside material and be insoluble to CO under the pressure about 7MPa 2Be deposited in the separator bottom, extracting solution flows into second separator by first separator after reducing pressure, contain polysaccharide material and be insoluble to CO under the pressure about 2MPa 2, this moment, temperature was controlled at 18~21 ℃, and desired substance is deposited in the bottom of separator, CO 2Reclaim through second separator, the semi-finished product after secondary separates are the extractum shape, all take out;
C. the fast household freezer that extractum shape semi-finished product are taken out through negative 183 ℃ is frozen into lyophilized powder;
D. pulverize dry powder at least 100 purpose powder and sieve;
E. the powder that will sieve again is filled to through between the sterile working in No. 0 soft gelatin capsule, and every heavy 0.5g can adorn the box seal, packaging and warehousing.
The supercritical CO of Cai Yonging in force 2Fluid extraction technology extracts and is mature technique comparatively, and the parameter difference of some temperature of physics of the present invention, pressure is specially: 3 kinds of Chinese medicinal powder such as Folium Mori and Poria are placed extractor, begin to carry out supercritical CO 2Extraction, condition is pressure 38~46MPa, 38~45 ℃ of temperature, supercritical CO 2The extractor of from bottom to top flowing through, extracting solution flows to first separator after the air relief valve decompression, contain the glycoside product and be insoluble to CO under the pressure about 7MPa 2Be deposited in the separator bottom.Extracting solution flows into second separator by first separator after reducing pressure, contain polysaccharide product class product and be insoluble to CO under the pressure about 2MPa 2, this moment, temperature was controlled at 18~21 ℃, and required product is deposited in the bottom of separator, CO 2The semi-finished product that extract through the second separator recycling use are the extractum shape, and the fast household freezer that extractum shape semi-finished product are taken out through negative 183 ℃ is frozen into lyophilized powder.
The purity of carbon dioxide is 95~98% when implementing, and required capital equipment is a supercritical CO 2Extraction equipment, disintegrating apparatus and cryotherapy equipment.
Embodiment 1
A. Chinese medicines such as Folium Mori, Poria, Rhizoma Dioscoreae are cleaned up section, section back natural drying, crushed after being dried becomes 65 order powder;
B. adopt supercritical CO 2Fluid extraction technology extracts, and is specially: 3 kinds of Chinese medicinal powder such as Folium Mori and Poria are placed extractor, and their percentage by weight is Folium Mori 32.5%, Poria 33%, Rhizoma Dioscoreae 34.5%.Begin to supply with supercritical CO 2Extraction, CO 2Purity be 95%., condition is pressure 35MPa, 36 ℃ of temperature, supercritical CO 2The extractor of from bottom to top flowing through, extracting solution flows to first separator after the air relief valve decompression, contain the glycoside product and be insoluble to CO under the pressure about 7MPa 2Be deposited in the separator bottom, extracting solution flows into second separator by first separator after reducing pressure, contain the polysaccharide product and be insoluble to CO under the pressure about 2MPa 2, this moment, temperature was controlled at about 20 ℃, and required product is deposited in the bottom of separator, CO 2The semi-finished product that extract through the second separator recycling use are the extractum shape.
C. the fast household freezer that extractum shape semi-finished product are taken out through negative 183 ℃ is frozen into lyophilized powder.
D. pulverize dry powder at least 100 purpose powder and sieve.
Embodiment 2
Production method is pressed example 1, only is that some physical parameters change, and is specially:
A. Folium Mori, Poria, Rhizoma Dioscoreae 3 flavor Chinese medicines are cleaned up section, section back natural drying, crushed after being dried becomes 70 order powder;
B. adopt supercritical CO 2Fluid extraction technology extracts, and is specially: Folium Mori and Poria 3 flavor Chinese medicinal powder are placed extractor, and their percentage by weight is Folium Mori 32%, Poria 33.5%, Rhizoma Dioscoreae 34.5%.Begin to supply with supercritical CO 2Extraction, CO 2Purity be 96%., condition is pressure 45MPa, 42 ℃ of temperature, supercritical CO 2The extractor of from bottom to top flowing through, extracting solution flows to first separator after the air relief valve decompression, contain the glycoside product and be insoluble to CO under the pressure about 7MPa 2Be deposited in the separator bottom, extracting solution flows into second separator by first separator after reducing pressure, contain the polysaccharide product and be insoluble to CO under the pressure about 2MPa 2, this moment, temperature was controlled at about 19 ℃, and required product is deposited in the bottom of separator, CO 2The semi-finished product that extract through the second separator recycling use are the extractum shape.
C. the fast household freezer that extractum shape semi-finished product are taken out through negative 183 ℃ is frozen into lyophilized powder.
D. pulverize dry powder at least 120 purpose powder and sieve.
Embodiment 3
A. Folium Mori, Poria, Rhizoma Dioscoreae 3 flavor Chinese medicines are cleaned up section, section back natural drying, crushed after being dried becomes 80 order powder;
B. adopt supercritical CO 2Fluid extraction technology extracts, and is specially: 3 kinds of Chinese medicinal powder such as Folium Mori and Poria are placed extractor, and their percentage by weight is Folium Mori 33.5%, Poria 32%, and Rhizoma Dioscoreae 34.5% begins to supply with supercritical CO 2Extraction, CO 2Purity be 97%., condition is pressure 35MPa, 36 ℃ of temperature, supercritical CO 2The extractor of from bottom to top flowing through, extracting solution flows to first separator after the air relief valve decompression, contain the glycoside product and be insoluble to CO under the pressure about 7MPa 2Be deposited in the separator bottom, extracting solution flows into second separator by first separator after reducing pressure, contain the polysaccharide product and be insoluble to CO under the pressure about 2MPa 2, this moment, temperature was controlled at about 20 ℃, and required product is deposited in the bottom of separator, CO 2The semi-finished product that extract through the second separator recycling use are the extractum shape.
C. the fast household freezer that extractum shape semi-finished product are taken out through negative 183 ℃ is frozen into lyophilized powder.
D. pulverize dry powder at least 100 purpose powder and sieve.

Claims (3)

1. use supercritical CO 2Extraction extracts the raw material of blood sugar regulation in the plant, and it is characterized in that: described raw material is Powdered and is made up of Folium Mori, Poria, Rhizoma Dioscoreae, and their weight percentages of components is Folium Mori 33~34%, Poria 33~34%, Rhizoma Dioscoreae 34~35%.
2. by the described supercritical CO of using of claim 1 2Extraction extracts the preparation method of the raw material of blood sugar regulation in the plant, it is characterized in that:
A. Folium Mori, Poria, Rhizoma Dioscoreae 3 flavor Chinese medicines are cleaned up section, section back natural drying, crushed after being dried becomes 65~70 order powder;
B. adopt supercritical CO 2Fluid extraction technology extracts, and is specially: Folium Mori, Poria, 3 kinds of Chinese medicinal powder of Rhizoma Dioscoreae are placed extractor, begin to supply with supercritical CO 2Extraction, condition is pressure 38~46MPa, 38~45 ℃ of temperature, supercritical CO 2The extractor of from bottom to top flowing through, extracting solution flows to first separator after the air relief valve decompression, contain the glycoside product and be insoluble to CO under the pressure about 7MPa 2Be deposited in the separator bottom, extracting solution flows into second separator by first separator after reducing pressure, contain polysaccharide material and be insoluble to CO under the pressure about 2MPa 2, this moment, temperature was controlled at 18~21 ℃, the required bottom that polysaccharide material is deposited in separator, the CO of containing 2Reclaim through second separator, the semi-finished product after secondary separates are the extractum shape, all take out;
C. the fast household freezer that extractum shape semi-finished product are taken out through-183 ℃ is frozen into lyophilized powder;
D. pulverize dry powder at least 100 purpose powder and sieve.
3. by the described supercritical CO of using of claim 2 2Extraction extracts the preparation method of the raw material of blood sugar regulation in the plant, and it is characterized in that: the purity of carbon dioxide is 95~98%, and required capital equipment is a supercritical CO 2Extraction equipment, disintegrating apparatus and cryotherapy equipment.
CN 01145563 2001-12-29 2001-12-29 Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method Pending CN1429594A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01145563 CN1429594A (en) 2001-12-29 2001-12-29 Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01145563 CN1429594A (en) 2001-12-29 2001-12-29 Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method

Publications (1)

Publication Number Publication Date
CN1429594A true CN1429594A (en) 2003-07-16

Family

ID=4678238

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01145563 Pending CN1429594A (en) 2001-12-29 2001-12-29 Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method

Country Status (1)

Country Link
CN (1) CN1429594A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103518910A (en) * 2012-06-13 2014-01-22 福州万丰和生物科技有限公司 Pine needle tea drink
CN107041558A (en) * 2017-06-20 2017-08-15 慧谷生命科技湖北有限公司 A kind of Poria cocos radix polygonati officinalis meal replacement powder suitable for diabetes
CN113017092A (en) * 2021-04-01 2021-06-25 吉林省特医食品生物科技有限公司 Fermentation type small molecule peptide mixed solution for regulating blood sugar and preparation method and application thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103518910A (en) * 2012-06-13 2014-01-22 福州万丰和生物科技有限公司 Pine needle tea drink
CN103518910B (en) * 2012-06-13 2015-02-25 福州万丰和生物科技有限公司 Pine needle tea drink
CN107041558A (en) * 2017-06-20 2017-08-15 慧谷生命科技湖北有限公司 A kind of Poria cocos radix polygonati officinalis meal replacement powder suitable for diabetes
CN113017092A (en) * 2021-04-01 2021-06-25 吉林省特医食品生物科技有限公司 Fermentation type small molecule peptide mixed solution for regulating blood sugar and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN105638910B (en) preparation method and application of blood sugar-reducing high-dietary-fiber soybean milk powder
CN107412721B (en) Blood sugar-reducing bitter gourd polypeptide compound capsule and preparation method thereof
CN111840363A (en) Novel natto health-care composition assisting in reducing blood sugar and preparation method and application thereof
CN105613937A (en) Preparation method of momordica charantia p-polypeptide freeze-dried powder
WO2021078288A1 (en) Activated insulin, compound momordica charantia peptide oral medicine for treatment of diabetes, and preparation method
CN108186803A (en) The preparation process of compound oral liquid for tonifying blood containing red skin of peanut
CN110151860A (en) A kind of preparation method and its usage of black fruit fructus lycii extract
CN108570116B (en) Pleurotus citrinopileatus polysaccharide, preparation method and medical application in preventing and treating diabetes
CN1429594A (en) Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method
CN111000947A (en) Composition for reducing blood sugar and body fat and preparation method and application thereof
CN108077512B (en) Moringa oleifera leaf blood sugar reducing tea and preparation method thereof
CN107440114B (en) Composition with PM2.5 particle resistance effect
KR101058964B1 (en) Feed for duck containing extract from galic and coriandrum sativum,method for manufacturing the duck, duck feeding the duck,and duck meat and eggs by the duck
CN1273152C (en) Capsule for treating diabetes and productive method thereof
CN108969580B (en) Preparation method and application of blue cloth total tannin
KR101778142B1 (en) Old Platycodon Composit Composition Enhanced Antidiabetic Activity
CN112494520A (en) Application of gecko or extract thereof in preparing anti-depression drug
CN110013497A (en) A kind of Chinese medicinal soft capsule preparation process that immunity can be improved
CN108324746A (en) A kind of medicine materical crude slice and preparation method thereof that preventives treatment of disease made of Cordyceps militaris and eucommia Bark male flower
CN117099892B (en) Anti-fatigue fermented beverage containing bifidobacterium lactis SF-B21 and preparation process thereof
CN117679485B (en) Pueraria peptide and application thereof
KR101058956B1 (en) Feed for cattle containing extract from galic and coriandrum sativum, method for manufacturing the cattle,cattle feeding the cattle,and meat and milk by the cattle
CN111803559B (en) Eggplant peel composition with blood sugar reducing effect and preparation method and application thereof
KR102676880B1 (en) Method for manufacturing herbal medicines for improving sleep disorders and herbal medicines manufactured thereby
CN117257891B (en) Plant extract pharmaceutical composition for improving secretion of endogenous insulin-like growth factor 1

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication